Patent details

EP3098241 Title: FUSION PROTEIN INHIBITING ANGIOGENESIS OR GROWTH AND USE THEREOF

Basic Information

Publication number:
EP3098241
PCT Application Number:
CN2015071434
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157398934
PCT Publication Number:
WO2015110067
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FUSION PROTEIN INHIBITING ANGIOGENESIS OR GROWTH AND USE THEREOF
French Title of Invention:
PROTÉINE DE FUSION INHIBANT L'ANGIOGENÈSE OU LA CROISSANCE ET SON UTILISATION
German Title of Invention:
FUSIONSPROTEIN ZUR ANGIOGENESE ODER WACHSTUMSHEMMUNG UND VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
23/01/2015
Grant date:
25/10/2017
EP Publication Date:
30/11/2016
PCT Publication Date:
30/07/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/10/2017
EP B1 Publication Date:
25/10/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/01/2018
Expiration date:
23/01/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2017
 
 

Name:
Chengdu Kanghong Biotechnologies Co., Ltd.
Address:
No. 36 Shuxi Rd Jinniu District, Chengdu, Sichuan 610036, China (CN)

Inventor

1

Name:
KE, Xiao
Address:
China (CN)

2

Name:
GAO, Xiaoping
Address:
China (CN)

Priority

Priority Number:
201410035738
Priority Date:
25/01/2014
Priority Country:
China (CN)

Classification

IPC classification:
A61K 38/00; A61K 38/17; A61P 27/02; A61P 35/00; C07K 14/71;

Publication

European Patent Bulletin

Issue number:
201743
Publication date:
25/10/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/05/2018 Outgoing Correspondence 1